Ventricular Fibrillation

• 

  Subject Areas on Research

  • 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. 
  • 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. 
  • 6-Month Outcomes in Patients With Implantable Cardioverter-Defibrillators Undergoing Renal Sympathetic Denervation for the Treatment of Refractory Ventricular Arrhythmias. 
  • A case of electrical storm in a liver transplant patient. 
  • A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. 
  • A comparison of the electrical ventricular fibrillation threshold with and without anesthesia. 
  • A four-shock Bayesian up-down estimator of the 80% effective defibrillation dose. 
  • A method for quantitating antifibrillatory effects of drugs after coronary reperfusion in dogs: improved outcome with bretylium. 
  • A mutation in TNNC1-encoded cardiac troponin C, TNNC1-A31S, predisposes to hypertrophic cardiomyopathy and ventricular fibrillation. 
  • A novel ultrasound technique to estimate right ventricular geometry during fibrillation. 
  • A quantitative measurement of spatial order in ventricular fibrillation. 
  • ATP1A3-Encoded Sodium-Potassium ATPase Subunit Alpha 3 D801N Variant Is Associated With Shortened QT Interval and Predisposition to Ventricular Fibrillation Preceded by Bradycardia. 
  • Activation during ventricular defibrillation in open-chest dogs. Evidence of complete cessation and regeneration of ventricular fibrillation after unsuccessful shocks. 
  • Administrative Codes for Capturing In-Hospital Cardiac Arrest. 
  • Alteration of ventricular fibrillation by propranolol and isoproterenol detected by epicardial mapping with 506 electrodes. 
  • Amiodarone and reperfusion ventricular fibrillation. 
  • An unusual case of ventricular fibrillation. 
  • Analysis of the defibrillation efficacy for 5-ms waveforms. 
  • Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction. 
  • Applying the new STEMI guidelines: 2. Disturbances of cardiac rhythm after ST-segment elevation myocardial infarction. 
  • Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? 
  • Atrial fibrillation in the preexcitation syndrome. 
  • Cardiac arrest complicating acute myocardial infarction: predictability and prognosis. 
  • Cardiac mapping at Duke Medical Center. 
  • Cardioplegia and ventricular late potentials in cardiac surgical patients. 
  • Cardiovascular collapse caused by electrocardiographically silent 60-Hz intracardiac leakage current. Implications for electrical safety. 
  • Choosing the optimal monophasic and biphasic waveforms for ventricular defibrillation. 
  • Clinical predictors of survival in patients treated with therapeutic hypothermia following cardiac arrest. 
  • Comparison of activation during ventricular fibrillation and following unsuccessful defibrillation shocks in open-chest dogs. 
  • Comparison of upper limit of vulnerability and defibrillation probability of success curves using a nonthoracotomy lead system. 
  • Control of electrical alternans in simulations of paced myocardium using extended time-delay autosynchronization. 
  • Current density and electrically induced ventricular fibrillation. 
  • Current density and electrically induced ventricular fibrillation. 
  • Current density and electrically induced ventricular fibrillation. 
  • Death with an implantable cardioverter-defibrillator: a MADIT-II substudy. 
  • Defibrillation and the upper limit of vulnerability to fibrillation in a transthoracic guinea pig model. 
  • Defibrillation time intervals and outcomes of cardiac arrest in hospital: retrospective cohort study from Get With The Guidelines-Resuscitation registry. 
  • Defibrillators: Selecting the Right Device for the Right Patient. 
  • Depletion of myocardial high energy phosphates by induction of ventricular fibrillation prior to cardioplegic arrest. 
  • Does reducing capacitance have potential for further miniaturisation of implantable defibrillators? 
  • EFFECTS OF ELECTRIC SHOCK ON RESPIRATION IN THE RABBIT. 
  • ELECTRICAL HAZARDS ASSOCIATED WITH CARDIAC PACEMAKING. 
  • Early repolarization: a sword in the haystack? 
  • Early sustained ventricular arrhythmias complicating acute myocardial infarction. 
  • Effect of electrode surface area on thresholds for AC stimulation and ventricular fibrillation. 
  • Effect of pacing site on ventricular fibrillation initiation by shocks during the vulnerable period. 
  • Effect of pulse separation between two sequential biphasic shocks given over different lead configurations on ventricular defibrillation efficacy. 
  • Effect of rapid pacing and T-wave scanning on the relation between the defibrillation and upper-limit-of-vulnerability dose-response curves. 
  • Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator. 
  • Effect of the right ventricular isolation procedure on ventricular vulnerability to fibrillation. 
  • Effective defibrillation in pigs using interleaved and common phase sequential biphasic shocks. 
  • Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). 
  • Effects of monophasic and biphasic shocks on action potentials during ventricular fibrillation in dogs. 
  • Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. 
  • Efficient electrode spacing for examining spatial organization during ventricular fibrillation. 
  • Electric shock hazards in clinical cardiology. 
  • Electrical hazards and cardiovascular function. 
  • Electrocardiographic Early Repolarization: A Scientific Statement From the American Heart Association. 
  • Electrocardiographic factors playing a role in ischemic ventricular fibrillation in ST elevation myocardial infarction are related to the culprit artery. 
  • Electrocardiographic left ventricular hypertrophy predicts arrhythmia and mortality in patients with ischemic cardiomyopathy. 
  • Epicardial mapping of ventricular defibrillation with monophasic and biphasic shocks in dogs. 
  • Epicardial sock mapping following monophasic and biphasic shocks of equal voltage with an endocardial lead system. 
  • Evaluation of outpatients experiencing implantable cardioverter defibrillator shocks associated with minimal symptoms. 
  • Existence of both fast and slow channel activity during the early stages of ventricular fibrillation. 
  • Experimental cardiac tachyarrhythmias in guinea pigs. 
  • Experimental evidence for autowaves in the heart. 
  • Experimental evidence of improved transthoracic defibrillation with electroporation-enhancing pulses. 
  • Experimental verification of theoretical predictions concerning the optimum defibrillation waveform. 
  • Factors associated with ventricular inducibility in the MADIT-II study population. 
  • Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). 
  • Feedback to providers improves evidence-based implantable cardioverter-defibrillator programming and reduces shocks. 
  • Fibrillatory current thresholds & standards. 
  • Finite element analysis of bioelectric phenomena. 
  • Frequency dependence of the cardiac threshold to alternating current between 10 Hz and 160 Hz. 
  • Grand mal seizure during cardiopulmonary bypass: probable lidocaine toxicity. 
  • HAZARDS OF ELECTRIC SHOCK IN CARDIOLOGY. 
  • Hemodynamic collapse, geometry, and the rapidly paced upper limit of ventricular vulnerability to fibrillation by T-wave stimulation. 
  • High and low strength nonsynchronized shocks given during canine ventricular tachycardia. 
  • Images in clinical medicine. Internal ventricular defibrillation. 
  • Impact of percutaneous coronary intervention performance reporting on cardiac resuscitation centers: a scientific statement from the American Heart Association. 
  • Implantable Cardioverter Defibrillator Utilization and Mortality Among Patients ≥65 Years of Age With a Low Ejection Fraction After Coronary Revascularization. 
  • Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. 
  • Importance of electrode conductive surface area and edge effects on ventricular defibrillation efficacy. 
  • Improved defibrillation thresholds with large contoured epicardial electrodes and biphasic waveforms. 
  • Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. 
  • Incomplete relaxation between beats after myocardial hypoxia and ischemia. 
  • Influence of epicardial patches on defibrillation threshold with nonthoracotomy lead configurations. 
  • Influence of shock strength and timing on induction of ventricular arrhythmias in dogs. 
  • Is the second phase of a biphasic defibrillation waveform the defibrillating phase? 
  • Large sample test of defibrillation waveform sensitivity. 
  • Left ventricular geometry immediately following defibrillation: shock-induced relaxation. 
  • Magnesium therapy for refractory ventricular fibrillation. 
  • Management of pace-terminated ventricular arrhythmias. 
  • Mapping the electrical initiation of ventricular fibrillation. 
  • Mechanism of cardiac defibrillation. A different point of view. 
  • Mechanism of ventricular vulnerability to single premature stimuli in open-chest dogs. 
  • Mechanisms by which AC leakage currents cause complete hemodynamic collapse without inducing fibrillation. 
  • Mechanisms of ventricular fibrillation initiation in MADIT II patients with implantable cardioverter defibrillators. 
  • Metabolism of preconditioned myocardium: effect of loss and reinstatement of cardioprotection. 
  • Myocardial blood flow and oxygen consumption in the empty-beating, fibrillating, and potassium-arrested hypertrophied canine heart. 
  • New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience. 
  • No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). 
  • Novel intravascular defibrillator: defibrillation thresholds of intravascular cardioverter-defibrillator compared to conventional implantable cardioverter-defibrillator in a canine model. 
  • Open-thorax guinea pig model for defibrillation. 
  • Pericardial delivery of omega-3 fatty acid: a novel approach to reducing myocardial infarct sizes and arrhythmias. 
  • Phobic anxiety, depression, and risk of ventricular arrhythmias in patients with coronary heart disease. 
  • Postimplantation ventricular ectopic burden and clinical outcomes in cardiac resynchronization therapy-defibrillator patients: a MADIT-CRT substudy. 
  • Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score. 
  • Predicting patterns of epicardial potentials during ventricular fibrillation 
  • Predicting the potential gradient field in ventricular fibrillation from shocks delivered in paced rhythm. 
  • Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. 
  • Predictors of sustained ventricular arrhythmias in cardiac resynchronization therapy. 
  • Prevalence and Prognostic Significance of Left Ventricular Noncompaction in Patients Referred for Cardiac Magnetic Resonance Imaging. 
  • Prognostic importance of defibrillator shocks in patients with heart failure. 
  • Prognostic significance of postprocedural sustained ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention (from the HORIZONS-AMI Trial). 
  • Progressive ventricular dysfunction among nonresponders to cardiac resynchronization therapy: baseline predictors and associated clinical outcomes. 
  • Prolongation of repolarization time by electric field stimulation with monophasic and biphasic shocks in open-chest dogs. 
  • Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia. 
  • Prophylactic lidocaine use in acute myocardial infarction: incidence and outcomes from two international trials. The GUSTO-I and GUSTO-IIb Investigators. 
  • Putting class IIb recommendations to the test: the influence of unwitnessed and Non-VT/VF arrests on resource consumption and outcomes in therapeutic hypothermia and targeted temperature management. 
  • QT prolongation and dispersion in myocardial ischemia and infarction. 
  • RR-interval irregularity precedes ventricular fibrillation in ST elevation acute myocardial infarction. 
  • Random nature of fibrillation leads to the probabilistic nature of defibrillation. 
  • Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID Trial. 
  • Real-time detection and alerting for acute ST-segment elevation myocardial ischemia using an implantable, high-fidelity, intracardiac electrogram monitoring system with long-range telemetry in an ambulatory porcine model. 
  • Reassessing the role of antitachycardia pacing in fast ventricular arrhythmias in primary prevention implantable cardioverter-defibrillator recipients: Results from MADIT-RIT. 
  • Recent advances in the treatment of arrhythmias. 
  • Regional capture of fibrillating ventricular myocardium. Evidence of an excitable gap. 
  • Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry). 
  • Relationship of sustained ventricular tachyarrhythmias to outcomes in patients undergoing primary percutaneous coronary intervention with varying underlying baseline risk. 
  • Response by Friedman and Al-Khatib to Letter Regarding Article, "Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry". 
  • Response to letter regarding article, “sustained ventricular tachycardia and ventricular fibrillation complicating non–ST-segment elevation acute coronary syndromes”. 
  • Restitution in mapping models with an arbitrary amount of memory. 
  • Rigid and flexible thin-film multielectrode arrays for transmural cardiac recording. 
  • Risk stratification in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. 
  • Risk stratification of individuals with the Brugada electrocardiogram: a myth or a reality? 
  • Risks and challenges of implantable cardioverter-defibrillators in young adults. 
  • Role of NADPH oxidase and xanthine oxidase in mediating inducible VT/VF and triggered activity in a canine model of myocardial ischemia. 
  • Sex Differences in Inappropriate ICD Device Therapies: MADIT-II and MADIT-CRT. 
  • Skeletal muscle grafts applied to the heart. A word of caution. 
  • Spatial heterogeneity of restitution properties and the onset of alternans. 
  • Stellate Ganglion Blockade for the Treatment of Refractory Ventricular Arrhythmias. 
  • Stellate ganglion blockade for the treatment of refractory ventricular arrhythmias: A systematic review and meta-analysis. 
  • Stimulus-induced critical point. Mechanism for electrical initiation of reentry in normal canine myocardium. 
  • Strength-interval curves in canine myocardium at very short cycle lengths. 
  • Successful resuscitation after ropivacaine-induced ventricular fibrillation. 
  • Sudden cardiac arrest in ESRD patients. 
  • Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes. 
  • Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO-III trial. 
  • Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes. 
  • THE MECHANISMS OF DEATH FROM ELECTRIC SHOCK. 
  • THE NATURE AND MANAGEMENT OF ELECTRIC SHOCK. 
  • Task Force 7: arrhythmias. 
  • The comparative effects of drive and test stimulus intensity on myocardial excitability and vulnerability. 
  • The course of acute myocardial infarction. Feasibility of early discharge of the uncomplicated patient. 
  • The effect of chemical ablation of the endocardium on ventricular fibrillation threshold. 
  • The effect of inducing ventricular fibrillation with 50-Hz pacing versus T wave stimulation on the ability to defibrillate. 
  • The hazard of electrocution during patient monitoring. 
  • The impact of arrhythmias in acute heart failure. 
  • The preexcitation syndromes. 
  • The ventricular defibrillation and upper limit of vulnerability dose-response curves. 
  • Thresholds of fibrillating leakage currents along intracardiac catheters: an experimental study. 
  • Time-dependent risk reduction of ventricular tachyarrhythmias in cardiac resynchronization therapy patients: a MADIT-RIT sub-study. 
  • Two-dimensional analysis of ventricular fibrillation in the guinea pig. 
  • Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry. 
  • Ventricular arrhythmia in the X-linked cardiomyopathy Barth syndrome. 
  • Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy. 
  • Ventricular fibrillation in the Wolff-Parkinson-White syndrome. 
  • Ventricular fibrillation threshold for AC shocks of long duration, in dogs with normal acid-base state. 
  • Ventricular tachycardia and fibrillation detection by a sequential hypothesis testing algorithm. 
  • Wavelet formation in excitable cardiac tissue: the role of wavefront-obstacle interactions in initiating high-frequency fibrillatory-like arrhythmias. 
• 

  Keywords of People

  • Alexander, John Hunter Peel, Professor of Medicine, Medicine, Cardiology
  • Carboni, Michael Paul, Associate Professor of Pediatrics, Pediatrics, Cardiology
  • Granger, Christopher Bull, Professor of Medicine, School of Nursing
  • Landstrom, Andrew Paul, Associate Professor of Pediatrics, Cell Biology
  • Malkin, Robert A., Professor of the Practice Emeritus in the Department of Biomedical Engineering, Duke Science & Society
  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology